Out-of-Pocket Costs for Novel Guideline-Directed Diabetes Therapies Under Medicare Part D

This study examines cost sharing for novel second-line diabetes treatment agents under Medicare Part D.

Gardado en:
Detalles Bibliográficos
Publicado en:JAMA Intern Med
Main Authors: DeJong, Colette, Masuda, Camlyn, Chen, Randi, Kazi, Dhruv S., Dudley, R. Adams, Tseng, Chien-Wen
Formato: Artigo
Idioma:Inglês
Publicado: American Medical Association 2020
Assuntos:
Research Letter
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7490744/
https://ncbi.nlm.nih.gov/pubmed/32926091
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2020.2922
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares